On 1 March a two year programme began in the United Kingdom of phased transfer of all diabetics requiring insulin to insulin in a strength of 100 units/ml. Factors affecting the absorption of insulin from subcutaneous tissues include site of injection,' exercise,2 dose,3 strength of the insulin, volume, and the patient's age. 4 We examined the effect of giving identical doses of soluble insulin in strengths of U-40 (40 units/ml) and U-100 (100 units/ml).
Patients, methods, and results
Eight diabetic children aged 7-15 years were given on two successive mornings in hospital exactly comparable subcutaneous injections into the thigh of either U-40 or U-100 neutral insulin (Actrapid MC) followed by identical breakfasts and exercise. The previous evening they had received their normal dose of a combination of soluble and intermediate acting insulins. To avoid rapid hypoglycaemia the dose of insulin given was roughly two thirds of the usual total morning dose, the longer acting insulin being omitted. In four cases U-40 was given on the first morning followed by U-100 on the second morning, and in the other four cases the order was reversed. Blood glucose was measured half hourly for up to four hours after breakfast and the serum insulin concentration estimated on three occasions in each child. Samples were taken through an indwelling butterfly needle to avoid repeated venepuncture. Approval of the ethical committee was obtained.
Two patients were excluded from the study because of practical difficulties. Free insulin concentrations rose from a mean basal value of 30-5±SD mU/l in the subjects given U-40 insulin to a peak at 90 minutes of 58-8A28-3 mU/l. Patients' response to the same dose of U-100 insulin was a rise from a mean of 22-3 14-4 mU/l to 49 0± 1641 mU/l. Thus the increment in free insulin values was a mean of 28-3± 14-0 mU/l after U-40 insulin and 26-7_-24-0 mU/l after U-100 insulin.
The closely similar increments in free insulin concentrations after injections of U-40 and U-l00 were reflected in the parallel rise and fall of the blood glucose concentrations (figure). The figure was constructed from the mean blood glucose values of six patients at specific times after the insulin injections. Thus the concentrations rose from a mean of 8-1 mmol/l (146 mg/100 ml) to a peak of 14 6 mmol/l (263 mg/100 ml) at 90 minutes after U-40 insulin. The comparative figures for U-l00 insulin showed a rise from 9-6 mmol/l (173 mg/100 ml) to a peak of 16-0 mmol/l (288 mg/100 ml) at 90 minutes. The fasting blood glucose value on the second morning in hospital tended to be higher than on the first morning, which explained the discrepancy in fasting values between the two curves. Large increments in blood glucose values reflected the use of suboptimal doses of soluble insulin in this study. .o2r
Breakfast Minutes Exercise (walking) Mean and range of changes in blood glucose concentrations in six insulin dependent diabetics after suboptimal doses of U-40 and U-100 insulin.
Conversion: SI to traditional units-Blood glucose: 1 mmol/l 18 mg/100 ml.
Comment
Binder4 showed that absorption of insulin is decreased by increasing concentration and increasing volume of injected insulin. In changing from U-40 to U-100 insulin in identical doses these two factors appear to be balanced-that is, we are giving a smaller volume of an insulin of greater strength. These variations in absorption may be mediated by effects on subcutaneous blood flow, insulin having a vasoconstrictive effect.5
This study showed no apparent practical difference between the absorption and effects of U-40 and U-100 insulin when given as carefully controlled single injections. Further repeated dose studies during field trials with the new glass U-100 syringes confirmed this.
From these findings the change to U-100 insulin should present few problems from the standpoint of insulin action. Nevertheless, the use of glass syringes, which have a significant dead space, the difficulties of measuring very small doses of highly concentrated insulin, and the variable quality of injection techniques and injection sites are other factors which will require consideration when patients (particularly the very young and very old) change over from U-40 to U-100 insulin.
We thank Mrs C Owens, of the department of biochemistry at Bristol Maternity Hospital, for the insulin measurements. The IgG3 antibodies also appeared to be the predominant subclass, in that in all except one of the sera they gave the most intense fluorescence; in the exception (case 13) the antibody was predominantly in the IgG2 subclass. In a further extensive study of the subclass distribution of antinuclear antibodies in patients with systemic lupus erythematosus and rheumatoid arthritis (Riggioni and Thompson, unpublished observations) this subclass restriction was not observed. The serum IgM and IgG concentrations were significantly increased in the patients (p< 0 001) as compared with the controls. Within the IgG subclasses IgG3 was greatly increased (p< 0.001).
IgGl and IgG2 were also significantly increased (p<0.01) but to a less degree. There was no significant difference in IgG4 values.
In analysing IgG antibody responses several IgG subclass restrictions have been described both in animal models and in man3 4 and changes in the distribution of IgG subclasses have also been reported in disease.
Antimitochondrial antibody, which is a hallmark of primary biliary cirrhosis, was found predominantly in the IgG3 subclass, though in many patients weaker activity in other subclasses was also present. Since IgG3, which fixes complement readily, represents only about 8%/o of normal IgG this is a significant restriction in subclass expression. A restriction to this subclass has not previously been described for autoantibodies. While the role and significance of antimitochondrial antibodies in primary biliary cirrhosis is unknown, their strong association with this condition at least suggests that the aetiological factors which initiate the disease are similar to those that result in the formation of these particular antibodies.
Restriction of antibody responses to IgG3 has been reported in certain viral infections.5 Viruses have been implicated as aetiological factors in many autoimmune conditions, and our finding possibly provides some insight into the aetiology of the disease. On her return she was in the same childish but cheerful state. At the beginning of the third week after overdosage, however, hypothermia and tachycardia were noted, and one week later features of parkinsonism appeared. Axillary temperatures ranged from 35-6°to 36-7°and the heart rate from 90 to 120 beats/min. She had immobile facies and was salivating and showed a rigid gait. These effects lasted one month, during which she was
